Insider Trading Summary for Ars Pharmaceuticals, Inc. (SPRY): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
24-Apr-24 6:17 PM View:	23-Apr-24 Option Exercise Duplicate $138.99K	Lowenthal Richard E President and CEO Director 10% Owner		Ars Pharmaceuticals, Inc. - SPRY	(1%) 13.05M to 12.87M	0	0	--	--	Show Txns Hide Txns

24-Apr-24 6:18 PM View:	23-Apr-24 Option Exercise $138.99K	Tanimoto Sarina Chief Medical Officer 10% Owner		Ars Pharmaceuticals, Inc. - SPRY	(1%) 13.05M to 12.87M	0	0	--	--	Show Txns Hide Txns

05-Sep-23 8:04 PM View:	01-Sep-23 Planned Option Sale ($770.52K)	Shawver Laura Director		Ars Pharmaceuticals, Inc. - SPRY	0% 210.35K	0	0	--	--	Show Txns Hide Txns

02-Oct-23 4:23 PM View:	29-Sep-23 Purchase $174.99K	Fitzpatrick Alexander A Chief Legal Officer		Ars Pharmaceuticals, Inc. - SPRY	2905% 2.97K to 89.23K	0	0	--	--	Show Txns Hide Txns

31-Aug-23 5:18 PM View:	29-Aug-23 Purchase $3.10M	Thompson Peter A Director		Ars Pharmaceuticals, Inc. - SPRY	6% 8.74M to 9.24M	0	0	--	--	Show Txns Hide Txns

31-Aug-23 5:26 PM View:	29-Aug-23 Purchase Duplicate $3.10M	Orbimed Advisors LLC Director		Ars Pharmaceuticals, Inc. - SPRY	6% 8.74M to 9.24M	0	0	--	--	Show Txns Hide Txns

27-Mar-24 7:37 PM View:	27-Mar-24 Purchase $4.95M	Ra Capital Management, LLC Director 10% Owner		Ars Pharmaceuticals, Inc. - SPRY	261% 3.01M to 10.86M	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	0	--